BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 33180138)

  • 1. Light Chain Predominant Intact Immunoglobulin Monoclonal Gammopathy Disorders: Shorter Survival in Light Chain Predominant Multiple Myelomas.
    Singh G; Xu H
    Lab Med; 2021 Jul; 52(4):390-398. PubMed ID: 33180138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum Free Light Chain Assay in Monoclonal Gammopathic Manifestations.
    Lee WS; Singh G
    Lab Med; 2019 Oct; 50(4):381-389. PubMed ID: 30957173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concentrations of Serum Free Light Chains in Kappa and Lambda Lesions in Light-Chain Myelomas.
    Singh G
    Lab Med; 2019 Apr; 50(2):189-193. PubMed ID: 30423164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Impact of Serum Heavy/Light Chain Pairs in Patients With Monoclonal Gammopathy of Undetermined Significance and Smoldering Myeloma: Long-Term Results From a Single Institution.
    Magnano L; Fernández de Larrea C; Elena M; Cibeira MT; Tovar N; Aróstegui JI; Pedrosa F; Rosiñol L; Filella X; Yagüe J; Bladé J
    Clin Lymphoma Myeloma Leuk; 2016 Jun; 16(6):e71-7. PubMed ID: 27013181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urine Protein Immunofixation Electrophoresis: Free Light Chain Urine Immunofixation Electrophoresis Is More Sensitive than Conventional Assays for Detecting Monoclonal Light Chains and Could Serve as a Marker of Minimal Residual Disease.
    Singh G; Arinze N; Manthei DM; Plapp FV; Bollag RJ
    Lab Med; 2023 Sep; 54(5):527-533. PubMed ID: 36857478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reference change values of M-protein, free light chain and immunoglobulins in monoclonal gammopathy.
    Evliyaoglu O; van Helden J; Jaruschewski S; Imöhl M; Weiskirchen R
    Clin Biochem; 2019 Dec; 74():42-46. PubMed ID: 31526775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The predictive power of serum kappa/lambda ratios for discrimination between monoclonal gammopathy of undetermined significance and multiple myeloma.
    Bergón E; Miravalles E; Bergón E; Miranda I; Bergón M
    Clin Chem Lab Med; 2005; 43(1):32-7. PubMed ID: 15653439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Monoclonal gammopathy of undetermined significance and asymptomatic multiple myelom in the year 2014 ].
    Adam Z; Krejčí M; Pour L; Sevčíková E; Křivanová A; Rehák Z; Koukalová R; Cermáková Z; Vaníček J; Sevčíková S
    Vnitr Lek; 2014 Oct; 60(10):861-79. PubMed ID: 25382009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A rare case of IgE kappa monoclonal gammopathy of undetermined significance identified in a Swedish female.
    Fager Ferrari M; Lemonakis K; Förnvik Jonsson M
    Scand J Clin Lab Invest; 2021 Sep; 81(5):385-388. PubMed ID: 34097568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of different hematologic variables in defining the risk of malignant transformation in monoclonal gammopathy.
    Baldini L; Guffanti A; Cesana BM; Colombi M; Chiorboli O; Damilano I; Maiolo AT
    Blood; 1996 Feb; 87(3):912-8. PubMed ID: 8562962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and risk of progression of light-chain monoclonal gammopathy of undetermined significance: a retrospective population-based cohort study.
    Dispenzieri A; Katzmann JA; Kyle RA; Larson DR; Melton LJ; Colby CL; Therneau TM; Clark R; Kumar SK; Bradwell A; Fonseca R; Jelinek DF; Rajkumar SV
    Lancet; 2010 May; 375(9727):1721-8. PubMed ID: 20472173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
    Kyle RA; San-Miguel JF; Mateos MV; Rajkumar SV
    Hematol Oncol Clin North Am; 2014 Oct; 28(5):775-90. PubMed ID: 25212882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification of Free Immunoglobulin Light Chains in Urine.
    Singh G; Cotter T; Ye Mon M; Xu H; Bollag RJ
    J Appl Lab Med; 2023 Nov; 8(6):1101-1114. PubMed ID: 37725944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical Significance of Serum Free Light Chain in Monoclonal Gammopathy].
    Lu H; Zhang W
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Feb; 32(1):155-158. PubMed ID: 38387914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum and Urine Protein Electrophoresis and Serum-Free Light Chain Assays in the Diagnosis and Monitoring of Monoclonal Gammopathies.
    Singh G
    J Appl Lab Med; 2020 Nov; 5(6):1358-1371. PubMed ID: 33150391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis, risk stratification and management of monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
    van de Donk NW; Mutis T; Poddighe PJ; Lokhorst HM; Zweegman S
    Int J Lab Hematol; 2016 May; 38 Suppl 1():110-22. PubMed ID: 27161311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification by Ultrafiltration and Immunofixation Electrophoresis Testing for Monoclonal Serum Free Light Chains.
    Singh G; Bollag R
    Lab Med; 2020 Nov; 51(6):592-600. PubMed ID: 32285117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [AL amyloidosis presenting with fluminant multiorgan failure accompanied by rapid progression from MGUS to multiple myeloma].
    Tazoe K; Takakuwa T; Makuuchi Y; Kuno M; Harada N; Okamura H; Nishimoto M; Koh H; Nakashima Y; Nakamae H; Hino M
    Rinsho Ketsueki; 2022; 63(1):31-36. PubMed ID: 35135949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Monoclonal gammopathy of undetermined significance].
    Chaïbi P; Merlin L; Thomas C; Piette F
    Ann Med Interne (Paris); 2002 Nov; 153(7):459-66. PubMed ID: 12598832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. POEMS Syndrome with IgG-λ/IgA-κ Biclonal Gammopathy and Abnormal Serum Free Light Chain Ratio: a Case Report.
    Ham JY; Suh JS; Lee WK; Song KE
    Ann Clin Lab Sci; 2015; 45(6):702-6. PubMed ID: 26663802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.